Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Buzz Bomb Caffeine Company is a consumer health and nutraceutical company that specializes in the development and distribution of high-potency caffeine products. Operating as a subsidiary of Aspire Biopharma Holdings, the company focuses on the energy segment of the healthcare and wellness market. Its flagship product, BUZZ BOMB, is marketed as a unique caffeine delivery system designed for contemporary consumers seeking performance and alertness boosts. In early 2026, the company expanded its market reach through a significant distribution partnership with TruLife Distribution to target major retail channels. The business leverages pharmaceutical-grade sourcing to provide standardized caffeinated solutions for the functional beverage and supplement industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caffeine.